S&P 500   4,447.72 (-0.03%)
DOW   34,761.32 (-0.01%)
QQQ   371.08 (-0.51%)
AAPL   145.94 (-0.61%)
MSFT   297.48 (-0.69%)
FB   347.17 (+0.35%)
GOOGL   2,825.79 (+0.05%)
TSLA   762.60 (+1.19%)
AMZN   3,398.41 (-0.51%)
NVDA   219.02 (-2.58%)
BABA   145.63 (-3.68%)
NIO   35.58 (-1.19%)
CGC   14.04 (-3.57%)
GE   103.87 (+0.88%)
MU   74.21 (+0.23%)
AMD   105.13 (-0.96%)
T   27.26 (+0.26%)
F   13.86 (+1.09%)
ACB   6.02 (-2.11%)
DIS   175.84 (-0.23%)
PFE   44.22 (+0.07%)
BA   222.22 (+0.51%)
BAC   42.14 (+1.08%)
S&P 500   4,447.72 (-0.03%)
DOW   34,761.32 (-0.01%)
QQQ   371.08 (-0.51%)
AAPL   145.94 (-0.61%)
MSFT   297.48 (-0.69%)
FB   347.17 (+0.35%)
GOOGL   2,825.79 (+0.05%)
TSLA   762.60 (+1.19%)
AMZN   3,398.41 (-0.51%)
NVDA   219.02 (-2.58%)
BABA   145.63 (-3.68%)
NIO   35.58 (-1.19%)
CGC   14.04 (-3.57%)
GE   103.87 (+0.88%)
MU   74.21 (+0.23%)
AMD   105.13 (-0.96%)
T   27.26 (+0.26%)
F   13.86 (+1.09%)
ACB   6.02 (-2.11%)
DIS   175.84 (-0.23%)
PFE   44.22 (+0.07%)
BA   222.22 (+0.51%)
BAC   42.14 (+1.08%)
S&P 500   4,447.72 (-0.03%)
DOW   34,761.32 (-0.01%)
QQQ   371.08 (-0.51%)
AAPL   145.94 (-0.61%)
MSFT   297.48 (-0.69%)
FB   347.17 (+0.35%)
GOOGL   2,825.79 (+0.05%)
TSLA   762.60 (+1.19%)
AMZN   3,398.41 (-0.51%)
NVDA   219.02 (-2.58%)
BABA   145.63 (-3.68%)
NIO   35.58 (-1.19%)
CGC   14.04 (-3.57%)
GE   103.87 (+0.88%)
MU   74.21 (+0.23%)
AMD   105.13 (-0.96%)
T   27.26 (+0.26%)
F   13.86 (+1.09%)
ACB   6.02 (-2.11%)
DIS   175.84 (-0.23%)
PFE   44.22 (+0.07%)
BA   222.22 (+0.51%)
BAC   42.14 (+1.08%)
S&P 500   4,447.72 (-0.03%)
DOW   34,761.32 (-0.01%)
QQQ   371.08 (-0.51%)
AAPL   145.94 (-0.61%)
MSFT   297.48 (-0.69%)
FB   347.17 (+0.35%)
GOOGL   2,825.79 (+0.05%)
TSLA   762.60 (+1.19%)
AMZN   3,398.41 (-0.51%)
NVDA   219.02 (-2.58%)
BABA   145.63 (-3.68%)
NIO   35.58 (-1.19%)
CGC   14.04 (-3.57%)
GE   103.87 (+0.88%)
MU   74.21 (+0.23%)
AMD   105.13 (-0.96%)
T   27.26 (+0.26%)
F   13.86 (+1.09%)
ACB   6.02 (-2.11%)
DIS   175.84 (-0.23%)
PFE   44.22 (+0.07%)
BA   222.22 (+0.51%)
BAC   42.14 (+1.08%)
CNSX:CURE

Direxion Daily Healthcare Bull 3X Shares Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume44,500 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive CURE News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily Healthcare Bull 3X Shares and its competitors with MarketBeat's FREE daily newsletter.


About Direxion Daily Healthcare Bull 3X Shares

Biocure Technology Inc. develops and commercializes biopharmaceutical technologies for uses in recombinant and ranibizumab. The company is developing Interferons- Ã for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It is also developing CAR T Cell Therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and hair growth products. Biocure Technology Inc. was founded in 2005 and is headquartered in Vancouver, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Direxion Daily Healthcare Bull 3X Shares (CNSX:CURE) Frequently Asked Questions

What stocks does MarketBeat like better than Direxion Daily Healthcare Bull 3X Shares?

Wall Street analysts have given Direxion Daily Healthcare Bull 3X Shares a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Direxion Daily Healthcare Bull 3X Shares wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Direxion Daily Healthcare Bull 3X Shares' key executives?

Direxion Daily Healthcare Bull 3X Shares' management team includes the following people:
  • Dr. Sang Mok Lee Ph.D., Pres, CEO & Director (Age 55, Pay $101.38k)
  • Mr. Konstantin Lichtenwald CPA, CGA, CFO, Corp. Sec. & Director (Age 37, Pay $50k)
  • Mr. Marco Nonni, Consultant

What other stocks do shareholders of Direxion Daily Healthcare Bull 3X Shares own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily Healthcare Bull 3X Shares investors own include NVIDIA (nvda), Advanced Micro Devices (AMD), Gilead Sciences (gild), Merck & Co., Inc. (MRK), Micron Technology (MU), Spotify Technology (SPOT), Square (SQ), Tesla (TSLA), Abbott Laboratories (ABT) and AbbVie (ABBV).

What is Direxion Daily Healthcare Bull 3X Shares' stock symbol?

Direxion Daily Healthcare Bull 3X Shares trades on the CNSX under the ticker symbol "CURE."

How do I buy shares of Direxion Daily Healthcare Bull 3X Shares?

Shares of CURE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Direxion Daily Healthcare Bull 3X Shares' official website?

The official website for Direxion Daily Healthcare Bull 3X Shares is www.biocuretech.com.

How can I contact Direxion Daily Healthcare Bull 3X Shares?

The company can be reached via phone at 604-609-7149.


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.